These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11098616)

  • 1. [Chronic hepatitis. New therapeutic approaches on trial].
    Kaiser S
    MMW Fortschr Med; 2000 Oct; 142(43):61. PubMed ID: 11098616
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis and cholangitis. The liver at risk].
    MMW Fortschr Med; 1999 Jun; 141(25):20-1. PubMed ID: 10897899
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic viral hepatitis B and C. Hysteria and panic are no longer appropriate].
    Schwerdtfeger M; Fleig WE
    MMW Fortschr Med; 2000 Nov; 142(46):39-42. PubMed ID: 11132310
    [No Abstract]   [Full Text] [Related]  

  • 6. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
    Yalcin K; Degertekin H; Yildiz F; Kilinc N
    J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
    Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
    Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.
    Soza A; Hoofnagle JH
    Hepatology; 2003 Jul; 38(1):267. PubMed ID: 12830010
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
    MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].
    Tang Y; Chen G; Zheng R
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):89. PubMed ID: 11983118
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with natural interferon (alfaferone) in clinical practice--our experience].
    Dybowska D; Halota W
    Przegl Epidemiol; 2007; 61(1):17-22. PubMed ID: 17702434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiviral therapy in children with chronic hepatitis B and children with chronic hepatitis C].
    Zhang H; Zhu S
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):563-6. PubMed ID: 25224229
    [No Abstract]   [Full Text] [Related]  

  • 13. [An observation on antiviral effect of IFN--alpha N1 (Wellferon) in patients with chronic hepatitis B].
    Liu D; Wen X; Meng Q
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):125-8. PubMed ID: 12515188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HBeAg-negative chronic hepatitis].
    Ibragimova MM; Krel' PE; Abdurakhmanov DT
    Ter Arkh; 2004; 76(2):87-91. PubMed ID: 15106425
    [No Abstract]   [Full Text] [Related]  

  • 15. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.
    Mutimer D; Dowling D; Cane P; Ratcliffe D; Tang H; O'Donnell K; Shaw J; Elias E; Pillay D
    Antivir Ther; 2000 Dec; 5(4):273-7. PubMed ID: 11142622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment strategies for viral hepatitis].
    Matsushima T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):133-5. PubMed ID: 11968844
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of chronic viral hepatitis].
    Pache I; Mondada D; Moradpour D; Fontana M
    Rev Med Suisse; 2007 Jan; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.